A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study.
about
Concise review: Leukemia stem cells in personalized medicineA phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial.A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas.The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas.How I treat the peripheral T-cell lymphomasDenileukin Diftitox (Ontak) as Maintenance Therapy for Peripheral T-Cell Lymphomas: Three Cases with Sustained RemissionPeripheral T-cell lymphomas: a review of current approaches and hopes for the future.From empiric to mechanism-based therapy for peripheral T cell lymphoma.MLN8237 ( alisertib ) and its role in peripheral T-cell lymphoma.The role of alisertib in treatment of peripheral T-cell lymphomas.Investigational drugs for T-cell lymphoma.Therapeutic Options for Aggressive T-Cell Lymphomas.How to select the frontline treatment for a patient with peripheral T-cell lymphoma.Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.Suppressor Cell-Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis.Topotecan combined with Ifosfamide, Etoposide, and L-asparaginase (TIEL) regimen improves outcomes in aggressive T-cell lymphoma.Elevated serum interleukin-10 level and M2 macrophage infiltration are associated with poor survival in angioimmunoblastic T-cell lymphoma.Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas.Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital.Progress in Nanomedicine: Approved and Investigational Nanodrugs.Regulatory T Cells As Potential Targets for HIV Cure Research.
P2860
Q26995268-2FEBD0D9-8757-4191-90A5-1F39A4D2BDC2Q33428066-858D7B5C-6E5D-40C1-AE16-1C93E33C4A0AQ33429898-4909DB42-6C87-40DE-9891-B58B1E24D125Q33702181-CB3DED8A-3ED2-43DE-847D-F1E000508177Q35865090-FA696669-5067-4130-9D80-E394E9801E6EQ35882481-E9E093F9-ABE2-4609-B2EC-18B669D612A3Q38113568-058996EA-FAE2-4610-BA76-D61153FFD76AQ38186617-B704731A-AB9B-4E84-846D-7C9ABF5216E3Q38260926-F2389219-BAC1-49E1-ABEC-88C8040E24ECQ38581916-17488718-8A67-42BF-848F-B9568C385719Q38635909-E092E724-FB80-4D7C-AAE2-51858171E000Q38675843-C507CDDF-6327-465F-BEBF-E5DDC3860C7CQ38724551-2554DE76-1D69-4478-87CD-A9CCEA4140EDQ38853466-E1927179-76B8-45C9-B1FE-E24E7F61D9FDQ40070517-C5585DC9-BDEF-45DD-AAB0-A918092C688DQ45072628-D90EB2A4-4241-45BC-9E50-ABC8E04F9EAEQ47097471-4A093121-9CE7-4E55-9583-172A4C9E7A88Q48185230-995B19DF-336C-44F0-8499-13D68ACD9AA6Q48559035-D7A2AD82-1148-4B89-9E2D-BBD9B63E8E5DQ49188363-E7892605-BED7-4F23-AAAC-9116FFD21AC0Q52715799-ECA62B67-AB92-4098-A9D5-400F7A852162
P2860
A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A multicenter phase II trial t ...... l lymphoma: the CONCEPT study.
@en
A multicenter phase II trial t ...... l lymphoma: the CONCEPT study.
@nl
type
label
A multicenter phase II trial t ...... l lymphoma: the CONCEPT study.
@en
A multicenter phase II trial t ...... l lymphoma: the CONCEPT study.
@nl
prefLabel
A multicenter phase II trial t ...... l lymphoma: the CONCEPT study.
@en
A multicenter phase II trial t ...... l lymphoma: the CONCEPT study.
@nl
P2093
P2860
P1433
P1476
A multicenter phase II trial t ...... ll lymphoma: the CONCEPT study
@en
P2093
Eric Jacobsen
Francine M Foss
Kelly Pendergrass
Nelida Sjak-Shie
Rami Komrokji
Ranjana Advani
Vanessa Bolejack
P2860
P304
P356
10.3109/10428194.2012.742521
P577
2013-01-29T00:00:00Z